Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jessel MD"'
Autor:
Katherine Lutz, MD, Ryle Przybylowicz, MD, Khidir Dalouk, MD, Tamara M. Atkinson, MD, Yen Tibayan, MD, Peter M. Jessel, MD, FHRS
Publikováno v:
HeartRhythm Case Reports, Vol 10, Iss 9, Pp 681-684 (2024)
Externí odkaz:
https://doaj.org/article/39967ec20ec5410581bf5866de571503
Autor:
Kazi T. Haq, PhD, Nichole M. Rogovoy, BS, Jason A. Thomas, BS, Christopher Hamilton, BA, Katherine J. Lutz, MD, Ashley Wirth, BS, Aron B. Bender, MD, David M. German, MD, MPH, Ryle Przybylowicz, MD, Peter van Dam, PhD, Thomas A. Dewland, MD, FHRS, Khidir Dalouk, MD, Eric Stecker, MD, FHRS, Babak Nazer, MD, Peter M. Jessel, MD, FHRS, Karen S. MacMurdy, MD, FHRS, Ignatius Gerardo E. Zarraga, MD, FHRS, Bassel Beitinjaneh, MD, Charles A. Henrikson, MD, MPH, FHRS, Merritt Raitt, MD, FHRS, Cristina Fuss, MD, Maros Ferencik, MD, PhD, MCR, Larisa G. Tereshchenko, MD, PhD, FHRS, CCDS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 4, Pp 374-381 (2021)
Background: Adaptive cardiac resynchronization therapy (aCRT) is known to have clinical benefits over conventional CRT, but the mechanisms are unclear. Objective: Compare effects of aCRT and conventional CRT on electrical dyssynchrony. Methods: A pro
Externí odkaz:
https://doaj.org/article/f75534ef16bc4200924a61e6d306a100
Autor:
Merali N; Minimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust.; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey., Chouari T; Minimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey., Sweeney C; Minimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust., Halle-Smith J; Hepatobiliary and Pancreatic Surgery Unit, Queen Elizabeth Hospital Birmingham, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Jessel MD; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey., Wang B; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam., O' Brien J; Minimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust., Suyama S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge., Jiménez JI; Department of Life Sciences, Imperial College London., Roberts KJ; Hepatobiliary and Pancreatic Surgery Unit, Queen Elizabeth Hospital Birmingham, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Velliou E; Centre for 3D Models of Health and Disease, Division of Surgery and Interventional Science, University College London (UCL), London., Sivakumar S; Oncology Department and Institute of Immunology and Immunotherapy, Birmingham Medical School, University of Birmingham., Rockall TA; Minimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust., Demirkan A; Section of Statistical Multi-Omics, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey.; Surrey Institute for People-Centred AI, University of Surrey, Guildford, Surrey., Pedicord V; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge., Deng D; Department of Preventive Dentistry, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Giovannetti E; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam.; Fondazione Pisa per la Scienza, San Giuliano, Italy., Annels NE; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey., Frampton AE; Minimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust.; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey.
Publikováno v:
International journal of surgery (London, England) [Int J Surg] 2024 Oct 01; Vol. 110 (10), pp. 6771-6799. Date of Electronic Publication: 2024 Oct 01.
Autor:
Merali N; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK., Jessel MD; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK., Arbe-Barnes EH; UCL Institute of Immunity and Transplantation, The Pears Building, Pond Street, London, UK., Ruby Lee WY; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Gismondi M; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK., Chouari T; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK., O'Brien JW; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK., Patel B; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK., Osei-Bordom D; Liver and Digestive Health, University College London, Royal Free Hospital, Pond St, London, UK., Rockall TA; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK., Sivakumar S; Oncology Department and Institute of Immunology and Immunotherapy, Birmingham Medical School, University of Birmingham, Birmingham, UK., Annels N; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK., Frampton AE; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. Electronic address: aframpton@nhs.net.
Publikováno v:
HPB : the official journal of the International Hepato Pancreato Biliary Association [HPB (Oxford)] 2024 Jul; Vol. 26 (7), pp. 873-894. Date of Electronic Publication: 2024 Apr 26.
Autor:
Merali N; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Chouari T; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Terroire J; Surrey Institute for People-Centred AI, University of Surrey, Guildford GU2 7XH, UK.; Section of Statistical Multi-Omics, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Jessel MD; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Liu DSK; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK., Smith JH; Hepatobiliary and Pancreatic Surgery Unit, Queen Elizabeth Hospital Birmingham, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, UK., Wooldridge T; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Dhillon T; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Jiménez JI; Department of Life Sciences, Imperial College London, London SW7 2AZ, UK., Krell J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK., Roberts KJ; Hepatobiliary and Pancreatic Surgery Unit, Queen Elizabeth Hospital Birmingham, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, UK., Rockall TA; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK., Velliou E; Centre for 3D Models of Health and Disease, Division of Surgery and Interventional Science, University College London (UCL), London W1W 7TY, UK., Sivakumar S; Oncology Department, Institute of Immunology and Immunotherapy, Birmingham Medical School, University of Birmingham, Birmingham B15 2TT, UK., Giovannetti E; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.; Cancer Pharmacology Lab, AIRC Start Up Unit, Fondazione Pisana per la Scienza, San Giuliano Terme PI, 56017 Pisa, Italy., Demirkan A; Surrey Institute for People-Centred AI, University of Surrey, Guildford GU2 7XH, UK.; Section of Statistical Multi-Omics, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Annels NE; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK., Frampton AE; Minimal Access Therapy Training Unit (MATTU), Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7WG, UK.; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 28; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 28.
Autor:
Chouari T; Hepato-Pancreato-Biliary Department, Royal Surrey NHS Foundation Trust, Guildford GU2 7XX, UK.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7WG, UK., La Costa FS; Hepato-Pancreato-Biliary Department, Royal Surrey NHS Foundation Trust, Guildford GU2 7XX, UK., Merali N; Hepato-Pancreato-Biliary Department, Royal Surrey NHS Foundation Trust, Guildford GU2 7XX, UK.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7WG, UK.; The Minimal Access Therapy Training Unit, University of Surrey, Guildford GU2 7WG, UK., Jessel MD; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7WG, UK., Sivakumar S; Oncology Department and Institute of Immunology and Immunotherapy, Birmingham Medical School, University of Birmingham, Birmingham B15 2TT, UK., Annels N; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7WG, UK., Frampton AE; Hepato-Pancreato-Biliary Department, Royal Surrey NHS Foundation Trust, Guildford GU2 7XX, UK.; Section of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7WG, UK.; The Minimal Access Therapy Training Unit, University of Surrey, Guildford GU2 7WG, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Aug 25; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 25.